Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S de Bono

Showing results (11-20 of 492) with videos related to

Pageof 50
Sort By:
Current Problems in Cancer|June 7, 2017
Targeting DNA damage response systems to impact cancer careJoaquin Mateo, Johann S de Bono
European Urology|June 1, 2016
Reply to Vincenza Conteduca, Cristian Lolli, and Ugo De Giorgi's Letter to the Editor re: Pasquale Rescigno, David Lorente, Diletta Bianchini, et al. Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol 2016;70:724-31Pasquale Rescigno, Johann S de Bono
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Interrogating the Cancer Genome to Deliver More Precise Cancer CareJoaquin Mateo, Johann S de Bono
The New England Journal of Medicine|April 26, 2018
Metastatic Prostate CancerOliver Sartor, Johann S de Bono
Cancer Cell|July 15, 2020
Prostate Cancer 2020: "The Times They Are a'Changing"Alec Paschalis, Johann S de Bono
Nature|October 1, 2010
Translating cancer research into targeted therapeuticsJ S de Bono, Alan Ashworth
Current Opinion in Genetics & Development|November 30, 2010
Utilizing circulating tumor cells: challenges and pitfallsGerhardt Attard, Johann S de Bono
Current Urology Reports|March 1, 2012
Therapeutic options for advanced prostate cancer: 2011 updateAurelius Omlin, Johann S de Bono
European Journal of Cancer (Oxford, England : 1990)|September 28, 2011
Continued targeting of androgen receptor signalling: a rational and efficacious therapeutic strategy in metastatic castration-resistant prostate cancerDiletta Bianchini, Johann S de Bono
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2011
Translating scientific advancement into clinical benefit for castration-resistant prostate cancer patientsGerhardt Attard, Johann S de Bono
Pageof 50

Showing results (11-20 of 492) with videos related to

Sort By:
Pageof 50
Current Problems in Cancer|June 7, 2017
Targeting DNA damage response systems to impact cancer careJoaquin Mateo, Johann S de Bono
European Urology|June 1, 2016
Reply to Vincenza Conteduca, Cristian Lolli, and Ugo De Giorgi's Letter to the Editor re: Pasquale Rescigno, David Lorente, Diletta Bianchini, et al. Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol 2016;70:724-31Pasquale Rescigno, Johann S de Bono
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Interrogating the Cancer Genome to Deliver More Precise Cancer CareJoaquin Mateo, Johann S de Bono
The New England Journal of Medicine|April 26, 2018
Metastatic Prostate CancerOliver Sartor, Johann S de Bono
Cancer Cell|July 15, 2020
Prostate Cancer 2020: "The Times They Are a'Changing"Alec Paschalis, Johann S de Bono
Nature|October 1, 2010
Translating cancer research into targeted therapeuticsJ S de Bono, Alan Ashworth
Current Opinion in Genetics & Development|November 30, 2010
Utilizing circulating tumor cells: challenges and pitfallsGerhardt Attard, Johann S de Bono
Current Urology Reports|March 1, 2012
Therapeutic options for advanced prostate cancer: 2011 updateAurelius Omlin, Johann S de Bono
European Journal of Cancer (Oxford, England : 1990)|September 28, 2011
Continued targeting of androgen receptor signalling: a rational and efficacious therapeutic strategy in metastatic castration-resistant prostate cancerDiletta Bianchini, Johann S de Bono
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2011
Translating scientific advancement into clinical benefit for castration-resistant prostate cancer patientsGerhardt Attard, Johann S de Bono
Pageof 50